BioCryst Pharmaceuticals Ownership | Who Owns BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals Ownership Summary
BioCryst Pharmaceuticals is owned by 94.14% institutional investors, 1.26% insiders, and 4.60% retail investors. Vanguard group is the largest institutional shareholder, holding 10.58% of BCRX shares. BioPharma Credit Ord is the top mutual fund, with 8.23% of its assets in BioCryst Pharmaceuticals shares.
BCRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BioCryst Pharmaceuticals | 94.14% | 1.26% | 4.60% |
| Sector | Healthcare Stocks | 479.67% | 11.03% | -390.70% |
| Industry | Biotech Stocks | 295.80% | 10.97% | -206.77% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 21.89M | 10.58% | $164.62M |
| Blackrock funding, inc. /de | 21.43M | 10.24% | $191.98M |
| Blackrock | 19.96M | 9.68% | $123.33M |
| Kynam capital management, lp | 8.46M | 4.05% | $75.84M |
| State street | 7.50M | 3.62% | $56.39M |
| Alkeon capital management | 5.71M | 2.73% | $51.20M |
| Geode capital management | 4.82M | 2.33% | $36.28M |
| Deerfield management company, l.p. (series c) | 4.69M | 2.24% | $42.04M |
| Avoro capital advisors | 4.50M | 2.15% | $40.32M |
| Arrowstreet capital, limited partnership | 4.28M | 2.05% | $38.34M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rp management | 3.85M | 12.84% | $29.23M |
| Kynam capital management, lp | 8.46M | 8.16% | $75.84M |
| Caligan partners lp | 3.00M | 5.71% | $22.53M |
| Knott david m jr | 332.63K | 1.35% | $2.98M |
| Parkman healthcare partners | 1.01M | 1.04% | $9.03M |
| Eversept partners, lp | 1.21M | 1.00% | $10.82M |
| Rice hall james & associates | 2.06M | 0.99% | $18.46M |
| Rock springs capital management lp | 2.68M | 0.77% | $20.14M |
| Deerfield management company, l.p. (series c) | 4.69M | 0.76% | $42.04M |
| Avoro capital advisors | 4.50M | 0.71% | $40.32M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Arrowstreet capital, limited partnership | 4.28M | 0.03% | 4.08M |
| Assenagon asset management | 3.62M | 0.05% | 3.61M |
| Walleye capital | 2.30M | 0.08% | 2.15M |
| Vanguard group | 21.89M | 0.00% | 1.58M |
| Blackrock | 19.96M | 0.00% | 1.52M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avoro capital advisors | 4.50M | 0.71% | -4.20M |
| Braidwell lp | - | - | -3.38M |
| Price t rowe associates inc /md/ | 126.81K | 0.00% | -2.13M |
| Point72 asset management | - | - | -1.62M |
| Alkeon capital management | 5.71M | 0.09% | -1.50M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Hood river capital management | 1.24M | 0.16% | 1.24M | $11.15M |
| M&g | 1.05M | 0.05% | 1.05M | $9.41M |
| Driehaus capital management | 766.90K | 0.06% | 766.90K | $6.87M |
| Lord, abbett | 532.35K | 0.02% | 532.35K | $4.77M |
| Norges bank | 524.80K | 0.00% | 524.80K | $3.95M |
Sold Out
| Holder | Change |
|---|---|
| Tfo-tdc | -3.00 |
| Financial gravity asset management | -8.00 |
| Newedge advisors | -11.00 |
| Dinuzzo private wealth | -13.00 |
| Newbridge financial services group | -15.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 304 | 9.35% | 196,946,754 | 15.72% | 94 | 1.42% | 161 | 5.92% | 86 | 30.30% |
| Mar 31, 2025 | 277 | 2.59% | 174,118,175 | 3.86% | 83 | 1.27% | 150 | 29.31% | 66 | -25.00% |
| Dec 31, 2024 | 265 | -1.49% | 167,630,080 | -2.81% | 81 | 1.17% | 114 | -14.29% | 87 | 17.57% |
| Sep 30, 2024 | 268 | 7.63% | 172,429,027 | -1.07% | 83 | 1.17% | 134 | 5.51% | 73 | 8.96% |
| Jun 30, 2024 | 246 | -1.99% | 174,231,087 | -2.64% | 84 | 1.12% | 125 | 7.76% | 67 | -4.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BioPharma Credit Ord | 17.22M | 8.23% | 17.22M |
| Vanguard US Total Market Shares ETF | 6.57M | 3.14% | -18.55K |
| Vanguard Total Stock Mkt Idx Inv | 6.59M | 3.14% | -139.50K |
| iShares Russell 2000 ETF | 4.93M | 2.35% | -93.77K |
| SPDR® S&P Biotech ETF | 3.66M | 1.75% | 90.09K |
| ACAP Strategic A | 3.55M | 1.69% | 82.83K |
| Vanguard Small Cap Index | 2.54M | 1.21% | -17.21K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.25M | 1.07% | -987.45K |
| Fidelity Small Cap Index | 2.09M | 1.00% | 3.50K |
| iShares Russell 2000 Growth ETF | 1.84M | 0.88% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 13, 2025 | HEGGIE THERESA | - | Sell | $595.87K |
| Dec 13, 2024 | Hutson Nancy J | - | Sell | $52.78K |
| Jun 24, 2024 | McKee Amy E | - | Sell | $54.35K |
| Jun 17, 2024 | SANDERS MACHELLE | - | Sell | $28.13K |
| Jun 14, 2024 | HEGGIE THERESA | - | Sell | $40.92K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 1 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | 1 |
| 2024 Q3 | - | - |
BCRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools